OPDUALAG
NDC 0003-7125 · E.R. Squibb & Sons, L.L.C.
Generic namenivolumab and relatlimab-rmbw
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)NIVOLUMAB, RELATLIMAB
Strength12; 4 mg/mL; mg/mL
Pharmacologic classLymphocyte Activation Gene-3 Antagonists [MoA], Lymphocyte Activation Gene-3 Blocker [EPC], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Marketing categoryBLA
Packages
0003-7125-11 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0003-7125-11) / 20 mL in 1 VIAL, SINGLE-DOSE
Billed under HCPCS
J9298 — Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg Medicare Part B payment limit (ASP + 6%): $205.51
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0003-3120 — nivolumab and hyaluronidase-nvhy, 0003-3734 — nivolumab, 0003-3756 — nivolumab, 0003-3772 — nivolumab, 0003-3774 — nivolumab, 0003-6120 — nivolumab and hyaluronidase-nvhy